Singapore Hepatology
Conference 2024

26 July to 27 July 2024

8:30 am to 5:00 pm (SGT)

SHC 2024

26 July to 27 July 2024

8:30 am to 5.00 pm (SGT)

REGISTRATION FOR The Combined GIHep & Singapore Hepatology Conference includes SHC 2024!

We are committed to delivering Short, Focused Clinical Updates on all aspects of Hepatology from the World’s leading experts.

REGISTER HERE for the Combined Conference

To access SHC -e Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)

MEET SOME OF OUR EXPERTS

SHC 2024 Scientific Programme

July, 2024

26

Programme Time (SGT)
Welcome Remarks by the Conference Chairman and SHC partners 08:30 – 8:40
Chronic Hepatitis B symposium
Chairs: Prof. Junqi NIU, Prof. Harry Janssen, Prof. Rino Gani
Advances in HBV Cure 2024
Prof. Man Fung Yuen, Hong Kong View Bio
08:40 – 09:00
New guidelines for CHB
Prof. Jidong Jia, China View Bio
09:00 – 09:20
Debate: Should treatment be expanded
Yes: Prof. Man Fung Yuen, Hong Kong View Bio
No: Prof. Heiner Wedemeyer, Germany View Bio
09:20 – 09:40
Stopping nucleoside analogue therapy: worth the risk?
Prof. Harry Janssen, Netherlands View Bio
09:40- 10:00
Update on management of HBV flares
Prof. Teerha Piratvisuth, Thailand View Bio
10:00 – 10:20
Round table discussion/Case discussion 10:20 – 10:30
GSK Meet the Experts Tea Break
The building blocks of functional cure in HBV: Understanding the mechanisms and clinical considerations
10:30 – 11:20
Welcome and introduction
Prof. Lai Wei View Bio
The cornerstone: Defining the mechanisms needed to target functional cure
Prof. Kosh Agarwal View Bio and Prof. Lai Wei View Bio
The keystone: Measuring, monitoring and managing
Prof. Kosh Agarwal View Bio and Prof. Lai Wei View Bio
The capstone: Making functional cure last
Prof. Kosh Agarwal View Bio and Prof. Lai Wei View Bio
Summary and close
Prof. Lai Wei View Bio
Delta Cure Symposium
Chairs: Prof. Teerha Piratvisuth , Prof. Khin Maung Win
What is the prevalence of delta hepatitis and how do you diagnose it
Prof. Pei Jer Chen, Taiwan View Bio
11:20 – 11:40
What is delta cure and how to achieve it?
Prof. Pietro Lampertico, Italy View Bio
11:40 – 12:00
Treatment options for delta cirrhosis
Prof. Heiner Wedemeyer, Germany View Bio
12:00- 12:20
Round table/case discussion 12:20- 12:40
First GSK Symposium  (lunch)
Functional cure in HBV: Going the distance
12:40 – 14:00
Warm up: Introduction and housekeeping
Dr. Tatsuya Kanto View Bio
The functional cure triathlon: HBsAg loss, HBV-DNA suppression, and immune restoration
Prof. Lai Wei View Bio
Personal goals: What could functional cure mean for people living with CHB?
Dr. Thomas Tu View Bio
On the starting line: Current strategies to achieve functional cure
Dr. Tatsuya Kanto View Bio
Taking the torch: Future strategies that could achieve functional cure
Prof. Kosh Agarwal View Bio
Q&A
All Faculty
MASLD Symposium
Chairs: Prof. Yock Young Dan, Dr. Poh Seng Tan, Dr. Yin Mei Lee
NAFLD, MAFLD, MASLD – practical implications of a name change.
Dr. George Goh, Singapore View Bio
14:00 – 14:20
Community screening and care pathways in Fatty Liver Disease
Prof. Wah Kheong Chan, Malaysia View Bio
14:20 – 14:40
Selecting patients for pharmacological treatment
Prof. Sven Francque, Belgium View Bio
14:40 – 15:00
Debate: Vitamin E for NAFLD
Yes: Prof. Arun Sanyal, USA View Bio
No: Prof. Vincent Wong, Hong Kong View Bio
15:00 – 15:20
Pearls and pitfalls on how to use GLP1 agonists
Dr. Mark Muthiah, Singapore View Bio
15:20 – 15:40
Summary of the Second Singapore MASLD Symposium
Prof. Arun Sanyal, USA View Bio
15:40 – 16:00
Round table/case discussion 16:00 – 16:20
Fireside Chat with Hepatology experts: learning from the leaders
Moderator: Dr. Daniel Huang
Featuring Prof. Rajender Reddy, View Bio Dr. Anand V Kulkarni, India View Bio & Prof. Arun Sanyal, USA View Bio 17:20 – 18:00
End of day 1

July, 2024

27

Programme Time (SGT)
HCC Symposium
Chairs: Dr. Edhel Tripon, Dr. Wei Lyn Yang, Adj. A/Prof. Chee Cheng Ean
Hepatocellular surveillance: Barriers, gaps and new strategies
Dr. Ken Liu, Australia  View Bio
09:00 – 09:20
Role of non-invasive tests in NASH and HCC risk
Dr. Daniel Huang, Singapore View Bio
09:20 – 09:40
Debate: Adjuvant therapy for HCC Cure
Yes: Prof. Pierce Chow, Singapore
View Bio
No: Prof. Glenn Bonney, Singapore View Bio
09:40 –10:00
Updates in systemic therapy for HCC: the way forward
–  Adj. A/Prof. Chee Cheng Ean, Singapore View Bio
10:00 – 10:20
Round-table /case discussion 10:20 – 10:40
Tea Break 10:40 – 11:00
Other Liver Diseases 
Chairs: Dr. How Cheng Low, Dr. Kieron Lim, Prof. Bettina Hanssen
The forgotten disease: Alcoholic liver disease & MetALD
Prof. Ajay Duseja, India View Bio
11:00 – 11:20
Difficult to treat autoimmune hepatitis
Prof. Atsushi Tanaka, Japan View Bio
11:20 – 11:40
Biliary cirrhosis and sclerosing cholangitis: Update
Prof. Atsushi Tanaka, Japan View Bio
11:40- 12:00
When should we consider rare liver diseases and how to diagnose it?
Prof. Bettina Hanssen, Holland View Bio
12:00- 12:20
Round table/case discussion 12:20- 12:40
Lunch  12:40– 14:00
Advanced Liver Disease Management for the practising gastroenterologist/hepatologist
Chairs: Dr. Rinaldi Lesmana, Prof. Raj Reddy
Hepatorenal syndrome and point of care ultrasound.
Dr. Anand V Kulkarni, India View Bio
14:00 – 14:20
Acute on chronic liver failure
Prof. Ajay Duseja, India View Bio
14:20 – 14:40
Preventing progression and complications of cACLD.
Dr. Ken Liu, Australia  View Bio
14:40 – 15:00
When to refer patients for liver transplantation
Dr. Ruveena Bhavani Rajaram, Malaysia View Bio
15:00 – 15:20
Futility in liver transplantation
Prof. Rajender Reddy, USA View Bio
15:20 – 15:40
Round table/cases discussion 15:40 – 16:10
Closing comments from the Chairman 16:10 – 16:20

Who Should Attend?

The SHC 2024 programme is designed for clinicians, scientists nurse practitioners, pharmacists, from Asia, the Indian Sub-continent, Australia and New Zealand, to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field  of hepatology.

Our Attendees Include:

  • Hepatology experts.
  • Clinical, basic, and translational researchers.
  • Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
  • Primary care physicians.
  • Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
  • Trainees, and students in the disciplines listed above.

REGISTER HERE for the Combined Conference

To access SHC -e Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)

Call for Abstracts

25 to 28 July 2024

8.30 am to 5.00 pm (SGT)

We invite all interested parties to present their research papers. Click Below on Abstracts and Posters for further information.

Abstracts will be reviewed by the Abstract Selection Committee and accepted submissions will be posted on Abstract & Poster Gallery in our website and in the Poster Hall.

The Abstract/Poster information and submission page will be open shortly.